LivaNova PLC
NASDAQ:LIVN
LivaNova PLC
NASDAQ:LIVN
Price:
62.1 USD
0.24%
Updated:
May 13, 2024
LivaNova PLC
Capital Expenditures
|
LivaNova PLC
Capital Expenditures Peer Comparison
Comparables:
SN
LMDX
EKF
AGL
CREO
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Capital Expenditures
-$33.7m
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-6%
|
|
|
Smith & Nephew PLC
LSE:SN
|
Capital Expenditures
-$427m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Capital Expenditures
-$25m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Capital Expenditures
-£7m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-12%
|
|
|
Angle PLC
LSE:AGL
|
Capital Expenditures
-£1.3m
|
CAGR 3-Years
18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Capital Expenditures
-£3.3m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is LivaNova PLC's Capital Expenditures?
Capital Expenditures
-33.7m
USD
-33.7m
USD
Based on the financial report for Mar 31, 2024, LivaNova PLC's Capital Expenditures amounts to -33.7m USD.
What is LivaNova PLC's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-6%
-6%
Over the last year, the Capital Expenditures growth was -16%. The average annual Capital Expenditures growth rates for LivaNova PLC have been 1% over the past three years , 2% over the past five years , and -6% over the past ten years .
You don't have any saved screeners yet
